click links in text for more info
SUMMARY / RELATED TOPICS

Epimenides

Epimenides of Cnossos was a semi-mythical 7th or 6th century BC Greek seer and philosopher-poet. While tending his father's sheep, Epimenides is said to have fallen asleep for fifty-seven years in a Cretan cave sacred to Zeus, after which he awoke with the gift of prophecy. Plutarch writes that Epimenides purified Athens after the pollution brought by the Alcmeonidae, that the seer's expertise in sacrifices and reform of funeral practices were of great help to Solon in his reform of the Athenian state; the only reward he would accept was a branch of the sacred olive, a promise of perpetual friendship between Athens and Cnossus. Athenaeus mentions him, in connection with the self-sacrifice of the erastes and eromenos pair of Cratinus and Aristodemus, who were believed to have given their lives in order to purify Athens. In antiquity there were those who held the story to be mere fiction. Diogenes Laërtius preserves a number of spurious letters between Epimenides and Solon in his Lives of the Philosophers.

Epimenides was said to have prophesied at Sparta on military matters. He died in Crete at an advanced age. According to another story, he was taken prisoner in a war between the Spartans and Cnossians, put to death by his captors, because he refused to prophesy favourably for them. Pausanias reports; this was considered odd. Some modern scholars have seen this as evidence that Epimenides was heir to the shamanic religions of Central Asia, because tattooing is associated with shamanic initiation; the skin of Epimenides was preserved at the courts of the ephores in Sparta, conceivably as a good-luck charm. Epimenides is reckoned with Melampus and Onomacritus as one of the founders of Orphism. According to Diogenes Laertius, Epimenides met Pythagoras in Crete, they went to the Cave of Ida. Several prose and poetic works, now lost, were attributed to Epimenides, including a theogony, an epic poem on the Argonautic expedition, prose works on purifications and sacrifices, a cosmogony, oracles, a work on the laws of Crete, a treatise on Minos and Rhadymanthus.

Epimenides' Cretica is quoted twice in the New Testament. Its only source is a 9th-century Syriac commentary by Isho'dad of Merv on the Acts of the Apostles, discovered and translated by Prof. J. Rendel Harris in a series of articles in the Expositor. In the poem, Minos addresses Zeus thus: The "lie" of the Cretans is that Zeus was mortal. "Cretans, always liars," with the same theological intent as Epimenides appears in the Hymn to Zeus of Callimachus. The fourth line is quoted in Acts of the Apostles, chapter 17, verse 28; the second line is quoted, with a veiled attribution, in the Epistle to Titus, chapter 1, verse 12, to warn Titus about the Cretans. The "prophet" in Titus 1:12 is identified by Clement of Alexandria as Epimenides. In this passage, Clement mentions that "some say" Epimenides should be counted among the seven wisest philosophers. Chrysostom gives an alternative fragment: For a tomb, King, of you They made, who never died, but shall be, it is not clear when Epimenides became associated with the Epimenides paradox, a variation of the liar paradox.

Epimenides himself does not appear to have intended any irony or paradox in his statement "Cretans, always liars." In the epistle to Titus, there is a warning that "One of themselves a prophet of their own, the Cretians are alway liars, evil beasts, slow bellies." In the Middle Ages, many forms of the liar paradox were studied under the heading of insolubilia, but these were not associated with Epimenides. Non-canonical books referenced in the Bible This article incorporates text from a publication now in the public domain: Chisholm, Hugh, ed.. "Epimenides". Encyclopædia Britannica. 9. Cambridge University Press. P. 694. Zaykov, Andrey. Epimemdes' activities in Sparta. In: Journal of Ancient History. Moscow, 2002. No 4. P. 110-130. Laërtius, Diogenes. "The Seven Sages: Epimenides". Lives of the Eminent Philosophers. 1:1. Translated by Hicks, Robert Drew. Loeb Classical Library. Epimenides of Crete Fragments at demonax.info

Duško Stajić

Duško Stajić is a Bosnian former professional footballer. Stajić started his career with FK Rudar Ugljevik moving on to FK Proleter Zrenjanin in the Second League of FR Yugoslavia early in his career, played with Publikum Celje in the Slovenian PrvaLiga during the second half of 2004–05 and entire 2005-06 seasons, he played for FK Sarajevo in the Bosnian Premier League during the 2007-08 season. In December 2009, he was linked with a move to SPL sides St Mirren and Hamilton. In February 2010, Stajić left FK Modriča, signing for Rot Weiss Ahlen. On 28 April 2010, Rot-Weiss Ahlen announced they would not sign Stajić permanently following his loan, that he would return to FK Modriča. In summer 2010, since his club was relegated, he moved to FK Borac Banja Luka in the Premier League of Bosnia and Herzegovina. After a short spell in FK Sloboda Užice, he signed for NK Čelik Zenica. At the second half of the 2013–14 season he had a spell in Greek second tier side Iraklis Psachna, but in summer 2014 he was back in Bosnia this time to join newly promoted FK Mladost Velika Obarska.

Haowever in the following winter break he left Mladost and joined FK Jedinstvo Brodac playing in the Second League of the Republika Srpska where his goalscoring skills will return by making 9 goals in 13 appearances. He was Herzegovina national under-21 football team. Duško Stajić at RomanianSoccer.ro and StatisticsFootball.com Profile at Fodbal.idnes.cz Modriča players profiles at Modriča official site

Avid Radiopharmaceuticals

Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, based at the University City Science Center research campus in Philadelphia, Pennsylvania; the company has developed a radioactive tracer called florbetapir. Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease. Venture investors include Alta Partners, Osage University Partners, Safeguard Scientifics. Eli Lilly and Company announced on November 8, 2010, that they would acquire Avid for $800 million, with $300 million paid out up front and the balance paid on. Since the disease was first described by Dr. Alois Alzheimer in 1906, the only certain way to determine if a person indeed had the disease was to perform an autopsy on the patient's brain to find distinctive spots on the brain that show the buildup of amyloid plaque.

Doctors must diagnose the disease in patients with memory loss and dementia based on symptoms, as many as 20% of patients diagnosed with the disease are found after examination of the brain following death to not have had the condition. Other diagnostic tools, such as analysis of cerebrospinal fluid, magnetic resonance imaging scans looking for brain shrinkage and PET scans looking at how glucose was used in the brain, had all been unreliable. Avid built on research done by Drs. William Klunk and Chester Mathis who had developed a substance they called Pittsburgh compound B as a means of detecting amyloid plaque, after analyzing 400 prospective compounds and developing 300 variations of the substance that they had discovered might work. In 2002, a study performed in Sweden on Alzheimer's patients was able to detect the plaque in PET brain scans. Studies on a control group member without the disease did not find plaque, confirming the reliability of the compound in diagnosis. While the tool worked, Pittsburgh compound B relies on the use of carbon-11, a radioactive isotope with a half-life of 20 minutes that requires the immediate use of the material prepared in a cyclotron.

Dr. Skovronsky established Avid Radiopharmaceuticals in July 2005 with the goal of finding a dye that could be injected into the body, would cross the blood–brain barrier and attach itself to amyloid protein deposits in the brain. Avid raised $500,000 from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, as seed funding toward the development of a biological marker. Once they found a candidate dye, they attached the positron-emitting fluorine-18, a radioactive isotope with a half-life of nearly two hours, used annually in two million PET scans and that can last for as long as a day when prepared in the morning by cyclotron; the dye was licensed by Avid. Initial tests in 2007 on a patient at Johns Hopkins University Hospital diagnosed with symptoms of Alzheimer's disease detected plaque in a PET scan in areas where it was found in the brain. Further tests found that the scans detected plaque in patients with Alzheimer's, didn't find it in those without the diagnosis and found intermediate amounts in patients with early signs of dementia.

The tests found amyloid plaque in 20% of its test patients over age 60, in the normal range, but had performed worse than a control group on tests of mental acuity. In order to confirm if the dye was accurate in detecting Alzheimer's, an advisory committee at the Food and Drug Administration demanded that the team of Avid and General Electric perform a study to test their method. Avid established a study with a group of 35 hospice patients, some, diagnosed with dementia and others that had no memory problems; the participants and their families agreed that they would undergo the PET scans and would have their brains autopsied after their death by pathologists. After the study was conducted, Avid received confirmation in May 2010 that the results of the test were successful in distinguishing between those with Alzheimer's and those without the disease. In results presented in July 2010 to an international conference on Alzheimer's disease held in Hawaii, the company showed that for 34 out of the 35 hospice patients, scanned, the initial scan results were confirmed when pathologists counted plaque under a microscope and when a computerized scan of the plaque was performed on material from the autopsied brain.

The findings will require review by the FDA to confirm its reliability as a means of diagnosing the disease. If confirmed, the technique would provide a means to reliably diagnose and monitor the progress of Alzheimer's and would allow potential pharmaceutical treatments to be evaluated. In a study published in January 2011 in the Journal of the American Medical Association, Avid reported on the results of further studies conducted based on 152 test subjects who had agreed to receive the company's PET scans and to have their brains analyzed after death for definitive determination of the presence of amyloid plaques. Of the patients included in the study, 29 who died had autopsies performed on their brains and in all but one the brain autopsy results matched the diagnosis based on the PET scan taken before death. Avid's technique is being used to test the efficacy of Alzheimer's disease treatments being developed by other pharmaceutical firms as a means of determining the ability of the drugs to reduce the buildup of amyloid protein in the brains of living subjects.

On January 20, 2011, an FDA advisory committee unanimously recommended that Avid's PET scan technique be approved for use. The advisory committee included a qualification requiring Avid to develop clear guidelines

Horse Guards Road

Horse Guards' Road is a road in the City of Westminster, London. It runs south from The Mall down to Birdcage Walk parallel with Whitehall and Parliament Street. To the west of the road is St James's Park and to the east are various government buildings, including the Horse Guards building, the Old Admiralty Buildings, the Cabinet Office, Downing Street, the Foreign and Commonwealth Office, HM Treasury. To the east is a large courtyard, Horse Guards Parade, where the annual Trooping the Colour ceremony is held in the presence of the reigning monarch

1955 in country music

This is a list of notable events in country music that took place in the year 1955. January 22 — Ozark Jubilee debuts on ABC-TV, the first popular country music show on network TV, it would run through September 1960. July 15 — Slim Whitman's "Rose Marie" becomes an international smash, debuting on the British charts and rising to No. 1. July 27 — Billboard magazine claims that Webb Pierce is one of only two singing stars that "can be considered guaranteed hitmakers these days". November 12 — Elvis Presley is voted the most promising country and western artist, according to Billboard magazine's annual disc jockey poll. 1955 was one of the most prolific years for new artists, many of whom would revolutionize country music. Some of the more prominent names were George Jones, Elvis Presley and Porter Wagoner. Many of them would go on to record and popularize the best known songs in the genre, have recording careers that lasted for decades, it would be more than 30 years before another gifted group this prominent would rise to fame and create a revolution in country music in a single year.

Note: Several songs were simultaneous No. 1 hits on the separate "Most Played in Juke Boxes," "Most Played by Jockeys" and "Best Sellers in Stores" charts. March 11 — Jimmy Fortune and member of The Statler Brothers. March 17 — Paul Overstreet, singer-songwriter who penned hit singles for artists such as Randy Travis and Tanya Tucker, had a career as a recording artist as well. March 26 — Dean Dillon, songwriter whose works were instrumental in the new traditionalist movement of the 1980s. March 28 — Reba McEntire and actress who has enjoyed fame since the early 1980s. May 11 — Mark Herndon, drummer with Alabama. May 12 — Kix Brooks, half of Brooks & Dunn. May 23 — Garry Koehler, Australian country musician and songwriter. May 24 — Rosanne Cash, daughter of Johnny Cash. July 1 — Keith Whitley, honky tonk-styled singer of the 1980s. September 24 — Lane Brody, female vocalist best known for dueting with Johnny Lee on 1984's "The Yellow Rose". November 1 — Keith Stegall, record producer who enjoyed a string of hits in the mid-1980s.

Kingsbury, Paul, "Vinyl Hayride: Country Music Album Covers 1947–1989," Country Music Foundation, 2003 Millard, Bob, "Country Music: 70 Years of America's Favorite Music," HarperCollins, New York, 1993 Whitburn, Joel. "Top Country Songs 1944–2005 – 6th Edition." 2005

Tanya Boeva

Tanya Boeva is a Bulgarian pop and Chalga singer. Tanya Boeva was born on November 3, 1973, in the town of Topolovgrad, but lived and grew up in Dimitrovgrad, she showed her musical talent at the age of two, her parents noticed it. When she was 13, she started singing in a school group called "Alchemists", she sang in various pubs. With the same group she won her first prize - "Golden Badge", at a festival in Haskovo; the performer started her professional career in 1994 when she recorded several songs with the Dimitrovgrad Orchestra. In 1995, she took part in the Golden Orpheus, where she won the Young Artist Award with the song Космичен блус; the following year she again participated in the festival with the song Сребрее косата ти рано, мамо in a duet with Daniela Petkova, won second prize. Following a contract with the music company Payner, Boeva released her debut album in 1997, containing only pop-songs; the album is called Обичай ме с нежност и душа English: Love me with tenderness and soul and the songs in it written by Dimitar Getov, Nayden Andreev, Vassil Iliev and Haigashod Agassyan.

Boeva received popularity and success after working with her producers of Ara Audio with which she released the album Дама пика in 1999. Since 2002, Tanya Boeva has been a self-producing performer, with the exception of In a short period of time partnering with Ara Music, who have acted as her managers. Tanya is married to Michaud Burgundzhiev and has a son called Rosen, born in 2007. In 2011, Tanya gave birth to a second son but he died 2 weeks afterwards from an unknown cause. Obichaj me s nezhnost i dusha - 1997 Shtastliva säm - 1998 Dama pika - 1999 Cherni ochi - 2000 Shock - 2001 Tanya Boeva - 2003 Lutam Se - 2004 Losho Momche - 2006 Losha Terapia - 2010 - The official website of Tanya Boeva